comparemela.com
2
3
4
5
6
7
8
Latest Breaking News On - Harma biotech - Page 1 : comparemela.com
Biocon shares rise 2% after turning profitable in Q3
The company s revenue from operations increased by 34.4 percent to Rs 3,953.7 crore
Biocon-biologics
Nitin-prabhakar-shenoy
Nicholas-robert-haggar
Biocon
Biocon-limited
Independent-director
Prabhakar-shenoy
Digital-transformation
3
Stock-market-news
Harma-biotech
Stocks
Anteris Technologies Ltd appoints highly experienced chief medical officer
The appointment of Dr Meduri, a recognised leader in the field of valvular heart disease, is expected to give further credibility to Anteris’ DurAVR™.
Anteri-dur
Wayne-paterson
Harvard-school-of-public-health
Beth-israel-deaconess-medical-center
Medicine-at-duke-university
Harvard-medical-school
Masters-in-public-health
Interventional-cardiologist
Advisory-board
Anteris-medical-advisory-board
Public-health
Clinical-effectiveness
Anteris Technologies Ltd extends manufacturing agreement with LeMaitre Vascular Inc for CardioCel™ and VascuCel™
Anteris Technologies is a structural heart company delivering clinically superior and durable solutions through better science and better design.
Australia
Wayne-paterson
Anteri-cardiocel
Lemaitre-vascular-inc
Maitre-vascular-inc
European-medical-devices-directorate
Small-caps
Tc-markets-quoted
Otcqb-quoted
Harma-biotech
Anteris-technologies-ltd
Sx-avr
Faron Pharmaceuticals PLC right in middle of fight against cancer and Coronavirus
Immunotherapy treatment Clevegen is on phase I/II trial (MATINS) for metastatic tumours
Finland
Deep-dive
Insight
Harma-biotech
Faron-pharmaceuticals-oy
Lon-farn
Roactiveinvestors
CytoDyn reveals data from its final mTNBC report with its flagship drug leronlimab
CytoDyn Inc CEO Nader Pourhassan shared an update to its previously reported preliminary results from its Phase 1b/2 trials and compassionate use of.
Nader-pourhassan
Creatv-microtech-inc
Cytodyn-inc
Progression-free-survival
Director-interviews
Harma-biotech
Cytodyn-inc
Otcmkts-cydy
Roactiveinvestors
vimarsana © 2020. All Rights Reserved.